China Everbright Water (U9E) renews six related-party framework agreements for 2026-28

SGX Filings
2025/12/11

China Everbright Water (U9E) said on Dec, 11 2025 that it has entered into six new framework agreements with parent China Everbright Group and major shareholder China Everbright Environment to govern recurring related-party transactions for the three years from Jan, 1 2026 to Dec, 31 2028.

The agreements cover: 1) Deposit services; 2) Loan services; 3) Underwriting and advisory services; 4) Sludge and hazardous-waste treatment services; 5) Property leasing; and 6) Employee health-insurance and welfare services.

Proposed annual caps include: • Daily maximum deposit balance (including interest) of about 26 million Singapore dollars each year. • Daily maximum loan balance (secured facilities) of about 26 million Singapore dollars each year. • Underwriting and advisory fees capped at roughly 3.5 million Singapore dollars per year. • Sludge and hazardous-waste treatment services capped at about 29 million Singapore dollars per year. • Property leasing payments capped at around 2.4 million Singapore dollars per year. • Employee health-insurance and related services capped at about 4.8 million, 5.5 million and 6.5 million Singapore dollars for 2026, 2027 and 2028, respectively.

Because the counterparties are deemed connected persons under Hong Kong’s listing rules, the transactions are classified as continuing connected transactions. The applicable percentage ratios are above 0.1% but below 5%, so the deals require announcement and annual review but are exempt from shareholder circular and independent shareholders’ approval.

China Everbright Water said the arrangements—renewed under the shareholder-approved interested-person transaction mandate granted at its Apr, 23 2025 annual general meeting—are on normal commercial terms and are expected to provide operational efficiency and cost benefits.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10